Endocrine Society Urges Congress to Avert Proposed Medicare Physician Payment Cuts

On July 7, the Center for Medicare and Medicaid Services (CMS) released the annual Medicare Physician Fee Schedule (MPFS) proposed rule. This rule outlines the agency’s proposed payment and quality program policies for the upcoming year.

This year’s rule proposes several important policy changes including allowing data collection on important telehealth services provided during the pandemic, revisions to reporting evaluation and management (E/M) services, and new codes proposed for billing the FDA-approved 180-day glucose sensor system. The rule also includes a 4.5% scheduled cut to the conversion factor. The Society is very concerned about this cut and is urging Congress to take action to avert it.

Every year, CMS requests our feedback on their proposed changes, and we respond by submitting a comment letter to the agency. Comments are due on September 7, 2022. We have worked with our Clinical Affairs Core Committee (CACC) and other Endocrine Society members with expertise in telehealth and quality payment issues.

If you are interested in learning more about this rule, you can visit the physician payment page on our website where you can find a one-pager and detailed summary of the rule. In addition, we will host a special Physician Payment Webinar in October to explain the impact of the proposed rule and how you can join our advocacy efforts to avert cuts.

You may also like

  • Funding for Federal Agencies Uncertain as Fiscal Year Deadline Approaches

    Endocrine Society Rallies for Increased Funding for the National Institutes of Health Congress is required to determine funding levels for all federal programs and agencies by October 1 when the new fiscal year begins. However, this year Congress is not on track to pass the 12 annual appropriations bills to fund the government by the…

  • The Endocrine Society is Advocating for You 

    Learn more about our advocacy and how you can get involved Today’s political environment is partisan, turbulent, and hard to navigate. Despite this challenge, the Endocrine Society works with the U.S. Congress, the White House, federal agencies, and global policymakers to influence the legislative and regulatory policies affecting endocrine-related research and practice. We advocate for…

Find more in